Keyword
Literature
toumei image Review Journal “Penetration”
We are happy to offer state-of-the-art commentaries on levofloxacin including Special Interviews with world-recognized experts as well as summaries of Review Articles on a variety of research areas of current interest, from our annual periodical, Penetration.

Special Issue 2015

dot Celebrating More Than 20 Years of Continued Use: Levofloxacin Remains a Mainstay of Antimicrobial Therapy NEW

Review

dot Newer Fluoroquinolones for the Treatment of Tuberculosis
Wing Wai Yew. 2011: 18-24
dot The Safety of Levofloxacin in Tuberculosis Treatment Including Drug-induced Hepatotoxicity
Chao-Chi Ho, Chong-Jen Yu. 2011: 25-31
dot The Role of Quinolones as Prophylaxis in Neutropenic Patients
Brahm H. Segal. 2011: 32-37
dot Review of the Second Asia-Pacific Consensus Guidelines for Helicobacter pylori Infection
Kwong Ming Fock, Tiing Leong Ang. 2011: 38-46
dot Susceptibility of Streptococcus pneumoniae and Haemophilus influenzae Collected Across Europe and Asia to Levofloxacin and Other Respiratory Agents; Results from GLOBAL Surveillance (1997-2007)
C. M. Pillar, C. Thornsberry, D. F. Sahm. 2010: 14-22
dot Investigation of Levofloxacin Regimens as Second-line Therapy for Helicobacter pylori
Simona Di Caro, Lucia Fini, Yayha Daud, Antonio Gasbarrini. 2010: 23-32
dot A Review of Levofloxacin for the Treatment of Complicated Urinary Tract Infections and Acute Pyelonephritis
Jessina C. McGregor, George P. Allen, David T. Bearden. 2010: 33-38
dot Levofloxacin in the Treatment of Pneumonia Caused by Streptococcus pneumoniae , Including Multidrug-Resistant Strains
Janet Peterson. 2010: 39-45
dot Meta-analysis Evaluating Respiratory Fluoroquinolones for Community-Acquired Pneumonia
Matthew E. Falagas, Konstantinos Z. Vardakas. 2010: 46-66
dot Levofloxacin and Its Effective Use in the Management of Bacterial Prostatitis
Kurt G. Naber. 2009: 21-26
dot High-Dose, Short-Course Levofloxacin for Complicated Urinary Tract Infections and Acute Pyelonephritis
Seth R. Strote, Howard A. Klausner. 2009: 27-32
dot The Susceptibility of Urinary Pathogens in Complicated Urinary Tract Infections
Richard D. David. 2009: 33-37
dot The Role of Levofloxacin in First-line and "Rescue" Helicobacter pylori Treatment Regimens
Javier P. Gisbert. 2009: 38-47
dot The Use of Fluoroquinolones as Prophylaxis in Neutropenia
Hamayun Imran, Imad M. Tleyjeh. 2009: 48-53
dot High-Dose Levofloxacin for the Treatment of Community-Acquired Pneumonia
Andrew F. Shorr. 2008: 13-18
dot Levofloxacin for the Treatment of Urosepsis
Ercole Concia, Anna Maria Azzini. 2008: 19-24
dot Resistance Challenges Threatening the Treatment of Pseudomonas aeruginosa Infections with Levofloxacin: The Role of a Levofloxacin-Imipenem Combination for Prevention of Resistance
Philip D. Lister, Daniel J. Wolter. 2008: 25-35
dot Successful Treatment of Helicobacter pylori Infections with Levofloxacin: A Case Report from Taiwan and a Review of the Literature
Jaw-Town Lin. 2008: 36-40
dot Levofloxacin: Today's Choice for the Treatment of Typhoid Fever?
An Illustrative Case Report from Indonesia
R. H. H. Nelwan. 2008: 41-44
dot Antimicrobial Susceptibility among Streptococcus pneumoniae: Data from the GLOBAL Study 2005/2006
Mark E. Jones, Nina P. Brown, Deborah C. Draghi, Clyde Thornsberry, Daniel F. Sahm. 2007: 15-22
dot Using Safety Profiles to Differentiate between the Newer Fluoroquinolones
Keith A. Rodvold. 2007: 23-30
dot Levofloxacin for the Treatment of Acute Exacerbation of Chronic Bronchitis: Position in Recent Guidelines
Hartmut M Lode. 2006: 21-27
dot Antimicrobial Chemotherapy for Legionnaires’ Disease: Levofloxacin Versus Macrolides
Rosa Ma Blázquez Garrido. 2006: 28-33
dot Clinical Safety Profile of Fluoroquinolones
Keith A Rodvold. 2006: 34-43
dot Levofloxacin for the Treatment of Respiratory Tract Infections Based on Treatment Guidelines
Chi-Huei Chiang. 2006: 44-51
dot Levofloxacin for the Treatment of Community-Acquired Pneumonia in the US Based on the Latest Treatment Guidelines
John G Bartlett. 2005: 15-20
dot The Experience of Using Levofloxacin in the Emergency Department
Sheng-Chuan Hu. 2005: 21-25
dot Clinical Usefulness of Levofloxacin for the Treatment of Urinary Tract Infections
Kurt G. Naber, Florian M. E. Wagenlehner. 2005: 26-32
dot The Diagnosis, Treatment and Management of Typhoid Fever and the Role of Fluoroquinolones
R.H.H. Nelwan. 2005: 33-38
dot Levofloxacin in the Treatment of Multi-Drug Resistant Streptococcus pneumoniae
Burke A. Cunha. 2005: 39-46
dot Role of Levofloxacin in the Treatment of Community-Acquired Pneumonia in Taiwan:In Vitro Activity and Clinical Efficacy
Po-Ren Hsueh 2004: 24-28
dot Early Switch Therapy from Intravenous to Oral Levofloxacin Versus Intravenous Ceftriaxone to Oral Cefuroxime Axetil in the Treatment of Moderate to Severe Community-Acquired Pneumonia
Hadiarto Manggunnegoro, Wahyuningsih Soeharno, Adria Rusli 2004: 29-35
dot Levofloxacin in the Treatment of Respiratory Tract Infections Due to Atypical Pathogens
Blasi F. Cosentini R. Tarsia P. 2003: 47-52
dot Levofloxacin in the Management of Lower Respiratory Tract Infections due to Typical Pathogens
Habib MP. 2003: 40-46
dot Use of Levofloxacin in the Treatment of Respiratory Tract Infections in an Era of Increasing Resistance: A Review of International Surveillance and TRUST Data
Jones ME. Thornsberry C. Karlowsky JA. Sahm DF. 2003: 33-40
dot An Overview: Appropriate Applications of PO and IV Therapy with Levofloxacin for Patients with Lower Respiratory Tract Infections
Fogarty CM. 2002: 29-36
dot Clinical efficacy and safety of levofloxacin for mild to moderate community-acquired pneumonia
Carbon C. 2002: 37-41
dot Levofloxacin for the Treatment of Severe Community-Acquired Pneumonia Patients with Risk Factors for Complications (Bacteremia and/or Sepsis)
Veyssier P. 2002: 42-48
dot Clinical Utilities of Sequential Therapy (Step-Down from Intravenous to Oral) with Levofloxacin for Hospitalized Patients with Lower Respiratory Tract Infections
Norby SR. 2001: 38-42
dot Levofloxacin for the Management of Patients with Community-Acquired Pneumonia: A Comparison of Bed Days per Patient Managed with Conventional Regimens
Marrie TJ. 2001: 43-47
dot Position of Levofloxacin in the Management of Bronchitis and Bronchiolitis
Shah PM. 2000: 22-26
dot New Strategies for the Management of Community-Acquired Pneumonia
Carbon C. 2000: 27-31
dot New Strategies for the Management of Legionnaires' Disease
Cunha BA. 2000: 32-39
dot New Strategies for the Management of Cystic Fibrosis and Bronchiectasis
Masterton RG. 2000: 40-46
dot New Strategies for the Management of Sinusitis
Adelglass J. 2000:47-51
dot In Vitro Activity of Levofloxacin against Penicillin-Resistant Streptococcus pneumoniae
Hu BS. 1999: 29-32
dot The Clinical Pharmacokinetics of Levofloxacin
Fish DN. 1999: 33-39
dot Drug-Drug Interactions Associated with Levofloxacin
Chow AT. Chien SC. 1999: 40-48
dot Levofloxacin in the Treatment of Community-Acquired Pneumonia
File TM. 1998: 26-30
dot Clinical Use of Levofloxacin for Intractable RTI in Outpatients
Kobayahshi H. 1998: 31-35
dot Clinical Efficacy of Levofloxacin in Skin and Soft Tissue Infection
Nicodemo A. 1998: 36-37
dot In Vitro and In Vivo Antimicrobial Activity of Levofloxacin.
Morrissey I. 1996: 41-45.


Special Interview

dot The Role of Levofloxacin in Treating Urinary Tract Infections
Richard GA. 2002: 5-16
dot Levofloxacin and Its Effective Use against RTI-Related Resistant Pathogens
Thornsberry C. 1999: 5-12.
dot A Comparison of Clinical Outcomes Using Levofloxacin versus ß-lactams and Macrolides in Respiratory Tract Infections
Smith RP. 1999: 18-23.
dot Levofloxacin - The "Respiratory Fluoroquinolone"
DeAbate CA. 1998: 5-10.
dot Levofloxacin in the Treatment of Community-Acquired Pneumonia.
Fogarty CM. 1997: 5-9.
dot Levofloxacin - An Extremely Useful Drug in the Treatment of Sinusitis.
Sydnor TA. 1997: 16-20.
dot Levofloxacin: Therapeutic Advances in the Treatment of Severe Infections.
Norrby SR. 1996: 5-10.


Special Message for the 21st Century

dot A Decade of Change and Future Possibilities
Rubinstein E. 2001: 5-6.
toumei image


image
toumei image ©1998- BIOMEDIS International, Ltd. All rights reserved. Reproduction in any manner in whole or part prohibited.
Disclaimer